Today: 1 July 2026
Browse Category

IPO News 14 December 2025 - 28 December 2025

Shanghai Stock Exchange Outlook: China’s 2026 Fiscal Signal, Yuan Strength, and STAR Market IPO Changes Set the Tone for the Next Session

Shanghai Stock Exchange Outlook: China’s 2026 Fiscal Signal, Yuan Strength, and STAR Market IPO Changes Set the Tone for the Next Session

NEW YORK, Dec. 28, 2025, 7:52 a.m. ET — Market closed The Shanghai Stock Exchange heads into the final stretch of the year with momentum still intact—but with a growing “show me the earnings” demand from investors as policy headlines and macro data collide. The benchmark Shanghai Composite ended Friday at 3,963.68, up 0.1%, with combined turnover across Shanghai and Shenzhen totaling about 2.16 trillion yuan, as gains in themes such as commercial spaceflight and lithium batteries helped offset weakness elsewhere. Xinhua News
Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

NEW YORK, Dec. 27, 2025, 4:10 p.m. ET — Market Closed Medtronic plc heads into the weekend with investors balancing a quiet, year-end tape against several company-specific narratives that still matter for 2026: a freshly passed dividend record window, the planned separation of its diabetes business via the MiniMed IPO process, and continued focus on cardiovascular momentum that has helped drive the stock’s 2025 run.
27 December 2025
Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

December 22, 2025 — Barrick Mining Corporation stock is ending the year with a rare triple tailwind: a fresh record in gold prices, a major geopolitical overhang easing in Mali, and an ongoing strategic shake-up that could materially change how the market values the company’s North American assets. Gold pushed through $4,400 per ounce for the first time on Monday, underscoring why miners have suddenly become the financial markets’ unlikely main characters again—part inflation hedge, part “rates are coming down” trade, part geopolitical insurance policy. Reuters
22 December 2025
Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Limited’s newly listed stock is doing what freshly public, hotly debated consumer-tech names often do: sprint, stumble, then dare investors to tell a coherent story about what “fair value” even means. On Monday, December 22, 2025, Meesho shares were trading around ₹209–₹212 by midday, down roughly 6–7% versus the prior close, after an eye-catching post-IPO surge that briefly pushed the company’s market cap toward the ₹1 trillion milestone. Business Standard+2Moneycontrol+2
22 December 2025
National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

Mumbai/Bengaluru — December 21, 2025 — The National Stock Exchange of India is ending 2025 in a situation that would have sounded contradictory a few years ago: India is home to one of the biggest derivatives machines on Earth, yet the country’s flagship equity market is behaving like it’s on sedatives. Options traders are being forced to rethink playbooks, regulators are still tightening the screws on speculation, and the exchange itself remains in the spotlight for a long-awaited IPO that’s still gated by settlements and governance clean-up. Because December 21, 2025 is a Sunday, the day’s “NSE story” is really a composite of what happened into the Friday close and what analysts are projecting for the holiday-shortened final stretch of the year.
21 December 2025
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease acquisition, a closely watched FDA approval in cardiology, IPO paperwork from both biotech and medtech, and a sweeping wave of U.S. drug-pricing headlines that could reshape sentiment into 2026. Investopedia+4Reuters+4Reuters+4 The setup matters because next week’s market structure will be unusual: U.S. stock markets are scheduled to close early on Wednesday, December 24 and remain closed on Thursday, December 25 for Christmas Day. That kind of thin liquidity can magnify single-stock moves—especially in biotech, where headlines often arrive without warning. New York Stock Exchange+2Nasdaq+2
Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

The Shanghai Stock Exchange heads into the final full trading stretch of 2025 with two stories unfolding at once: a steadier, policy-sensitive main board and a turbo-charged STAR Market where “hard tech” listings—especially AI chipmakers—are setting the tone for risk appetite. As of Sunday, Dec. 21, the latest official close for the benchmark Shanghai Composite Index is Friday’s session, when it rose 0.36% to 3,890.45. Xinhua News
21 December 2025
Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Ltd heads into the final stretch of 2025 with its stock trading close to a fresh 52-week peak—powered by a familiar Reliance cocktail: strong refining economics, rising confidence in consumer-facing cash flows, and a growing “value-unlocking” narrative around Jio. LiveMint+2Investing.com+2 RIL shares closed Friday, December 19, at ₹1,565.10, leaving the stock roughly 1% below the 52-week high around ₹1,581. The rally has been meaningful: Reliance is up about 28% year-to-date in 2025, comfortably outpacing the benchmark Sensex over the same period. LiveMint+1
Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

NEW YORK, Dec. 19, 2025 — Morgan Stanley stock traded higher Friday as investors weighed a cluster of catalysts: a Reuters report that the bank is emerging as a leading candidate to help run a potential SpaceX initial public offering, a drumbeat of upbeat industry outlooks for 2026 dealmaking, and a growing focus on Morgan Stanley’s upcoming fourth-quarter results in mid-January. Reuters+2Nasdaq+2 Shares were last indicated around $176.87, up about 2.3% on the session, with trading ranging from roughly $173.07 to $177.54 intraday, according to market data.
Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

December 19, 2025 — Navan, Inc. stock is sharply higher in Friday trading, putting the newly public corporate travel-and-expense platform back on traders’ screens just days after its debut earnings report triggered a steep selloff. The immediate catalyst: a notable open-market insider purchase disclosed in an SEC filing, which helped shift the day’s narrative from “post‑earnings pain” to “insider conviction.” SEC+1 As of late morning New York time, Navan stock traded around $15.27, up about 11% on the day. Even with today’s rebound, NAVN remains well below its $25 IPO price, a reminder that the market is still debating the company’s path from rapid growth to durable profitability. Navan
Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Inc. is getting a quick reality check after one of the biggest U.S. IPO debuts in years. After the closing bell on Thursday, December 18, 2025, Medline stock finished the regular session at $39.98 and traded around $39.49 in after-hours action, after moving between $38.00 and $41.74 during the day. Investing.com The timing matters: today wasn’t just “day two volatility.” Medline also officially closed its upsized IPO and confirmed that underwriters fully exercised their option for additional shares—an update that helps investors understand near-term share supply, stabilization mechanics, and how quickly the company can start paying down debt. Investing.com+1
18 December 2025
Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Updated: December 18, 2025 — Gujarat Kidney and Super Speciality Ltd has finalised the price band for its upcoming mainboard IPO, setting the stage for a ₹251 crore public issue that will open next week. The offer is entirely a fresh issue—meaning the company will receive the proceeds—at a time when investors are tracking healthcare listings closely for both growth visibility and execution risks. The Economic Times+1 The company has fixed the IPO price band at ₹108–₹114 per equity share. The public issue is scheduled to open on December 22, 2025 and close on December 24, 2025. The Economic Times+2Moneycontrol+2
18 December 2025
Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Updated: 4:40 PM ET The Nasdaq Stock Market closed sharply lower on Wednesday as renewed anxiety around the “AI trade” hit megacap technology and chip leaders, sending the Nasdaq Composite down 418.14 points to 22,693.32—a three-week low—despite a headline-grabbing IPO debut on the exchange and a late-day after-hours surge in Micron following blockbuster guidance. Reuters+2AP News+2
Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc confirmed the underwriting agreement and final prospectus filing for the ICICI Prudential Asset Management IPO, while continuing share repurchases and trading near a new 52‑week high. Prudential plc delivered a busy set of updates on Wednesday, 17 December 2025, putting its India-linked asset management monetisation and shareholder capital returns back in the spotlight.
17 December 2025
Meesho Limited Stock Jumps to Upper Circuit on Dec 17, 2025: UBS “Buy” Call, ₹220 Target, and What’s Next for Meesho Shares After the IPO

Meesho Limited Stock Jumps to Upper Circuit on Dec 17, 2025: UBS “Buy” Call, ₹220 Target, and What’s Next for Meesho Shares After the IPO

Meesho Limited shares surged sharply on December 17, 2025, hitting the 20% upper circuit and printing fresh record highs in early trade—an eye-catching move for a company that listed barely a week ago. The spark: a bullish UBS initiation that put a ₹220 target on the newly listed e-commerce stock, amplifying a rally that has already taken Meesho close to double its IPO issue price. Moneycontrol+2The Economic Times+2 As of late morning, market trackers showed Meesho trading around ₹216 with the day’s range stretching from roughly ₹186–₹216, and turnover/volumes running unusually hot—classic “new listing + fresh coverage + limited float” behavior. Depending on the data source and timestamp, Meesho’s market capitalisation was being pegged around ₹94,000–₹98,000 crore. Moneycontrol+2Screener+2
Reliance Industries Share Price Today (16 December 2025): RIL Stock in Focus on AI Unit Launch, Jio IPO Signals; Analyst Targets Cluster Around ₹1,700+

Reliance Industries Share Price Today (16 December 2025): RIL Stock in Focus on AI Unit Launch, Jio IPO Signals; Analyst Targets Cluster Around ₹1,700+

Mumbai, December 16, 2025 — Reliance Industries Limited shares were trading around ₹1,544 on Tuesday, down about 0.7%–0.8% intraday, as broader markets slipped under the weight of a weaker rupee and continued foreign selling pressure. The stock moved in a relatively tight band in early-to-mid trade, with an intraday range of roughly ₹1,539–₹1,552 and a 52-week range of ₹1,114.85–₹1,581.30, keeping it within striking distance of the year’s high even on a soft tape. Moneycontrol+1 Still, RIL remains one of the market’s most closely watched bellwethers—and today’s headlines underline why. A new corporate update around its artificial intelligence push has grabbed attention, while the broader “value-unlocking” narrative continues to shape how investors and analysts frame the stock heading into 2026. The Economic Times+2Reuters+2
ICICI Bank stock today (15 Dec 2025): ICICIBANK holds near ₹1,366 as ICICI Prudential AMC IPO draws strong demand; what analysts forecast next

ICICI Bank stock today (15 Dec 2025): ICICIBANK holds near ₹1,366 as ICICI Prudential AMC IPO draws strong demand; what analysts forecast next

ICICI Bank Limited is trading in a cautious Indian market on December 15, 2025, with the stock hovering around ₹1,366 in early-to-mid session ranges even as broader sentiment stays fragile on foreign outflows and a record-low rupee. Moneycontrol+2Reuters+2 What’s putting ICICI Bank back on investors’ radar today isn’t just the macro mood—it’s the high-profile IPO of ICICI Prudential Asset Management, where demand is coming in strongly, plus fresh disclosures around ICICI Bank’s majority stake and a Citi-hosted investor interaction scheduled for today. Reuters+2SEC+2
15 December 2025
Wakefit IPO Listing Today: Wakefit Innovations Shares Debut Flat at ₹195 on NSE, Slip Over 4% Soon After — What Investors Should Do

Wakefit IPO Listing Today: Wakefit Innovations Shares Debut Flat at ₹195 on NSE, Slip Over 4% Soon After — What Investors Should Do

Wakefit Innovations’ stock market debut on Monday, December 15, 2025 delivered a clear message: India’s primary market may be busy, but investors are becoming far more selective about valuation, near-term profitability, and listing-day upside. Wakefit shares opened at ₹195 on the NSE, matching the IPO issue price, while they listed at ₹194.10 on the BSE, a marginal discount. The Financial Express+2Business Standard+2 But the early calm didn’t last long—the stock slipped more than 4% in debut trading, with Reuters reporting it around ₹183.61 shortly after listing. Reuters
15 December 2025
Hong Kong Stock Market Week Ahead: HKEX Hang Seng Outlook After Fed Cut, China Data and IPO Momentum (Updated Dec 14, 2025)

Hong Kong Stock Market Week Ahead: HKEX Hang Seng Outlook After Fed Cut, China Data and IPO Momentum (Updated Dec 14, 2025)

HONG KONG — Hong Kong stocks head into the new week with a familiar tug-of-war: global rates are finally easing, but China’s growth trajectory and property risks still set the tone for risk appetite on the HKEX. The Hang Seng Index finished Friday at 25,976.79, jumping 1.8% on the day and trimming the week’s performance to a 0.4% decline—a rebound fueled by expectations of fresh pro-growth signals after Beijing’s annual economic policy meeting. South China Morning Post For the week ahead, traders will be watching three overlapping storylines:
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025. Destiny Tech100 Inc. just posted a sharp, high-volume run-up as investor attention snapped back to one theme: SpaceX IPO speculation—and what it could mean for public-market “access” vehicles tied to private tech leaders. But DXYZ isn’t a conventional operating company stock. It’s a closed-end management investment company built to hold a portfolio of late-stage private tech names, and it can trade far away from the value of its underlying assets. Destiny+1 Below is a detailed, publication-ready breakdown of this week’s move, the most important news from the last few days, and a week-ahead roadmap—including the key risk that keeps coming up in every serious DXYZ discussion: its large premium to NAV. Investing.com+1
14 December 2025
1 3 4 5 6 7 8

Stock Market Today

  • General Mills (GIS) tops Q4 earnings estimates, stock still lags S&P 500
    July 1, 2026, 9:57 AM EDT. General Mills (GIS) posted Q4 EPS of $0.95, ahead of the $0.82 consensus. Revenue was $4.61 billion, a slight beat. Shares are still down 25.2% on the year, far behind the S&P 500's 9.6% rise. The outlook stays cautious, with a Zacks Rank #4 (Sell) after recent estimate cuts. Wall Street is looking for $0.81 EPS and $4.38 billion sales next quarter. Management's guidance and industry news could move the stock soon.
Go toTop